E3 PreliminaryModerate confidencePEM unclearMethods-PaperPeer-reviewedMachine draft
Psychometric validation of the French Multidimensional Chronic Asthenia Scale (MCAS) in a sample of 621 patients with chronic fatigue.
Banovic, Ingrid, Scrima, Fabrizio, Fornasieri, Isabelle et al. · BMC psychology · 2023 · DOI
Quick Summary
Researchers tested a new questionnaire called the MCAS to measure chronic fatigue and exhaustion in French-speaking patients. The questionnaire asks about physical tiredness, how much fatigue limits daily life, and how it affects relationships. The study found that the MCAS works well and can detect differences in fatigue severity between people with different conditions, including ME/CFS.
Why It Matters
A validated, multidimensional fatigue measurement tool specific to French-speaking populations enables better clinical assessment and research consistency in ME/CFS. The MCAS captures both severity and qualitative differences in how fatigue manifests across physical, social, and lifestyle domains, supporting more nuanced patient outcomes evaluation.
Observed Findings
- The MCAS reliably produced four dimensions: feeling of constraint, physical consequences, life consequences, and interpersonal consequences
- CFS patients showed significantly greater impairment on MCAS dimensions compared to both active and inactive IBD groups
- MCAS dimension scores increased with longer duration of chronic asthenia, indicating sensitivity to disease chronicity
- Convergent validity with FSI and r-PFS was satisfactory overall, though some overlap existed between specific dimensions
- The MCAS successfully differentiated between-group differences in fatigue expression patterns
Inferred Conclusions
- The MCAS is a valid and reliable tool for measuring chronic asthenia severity and its multidimensional impact across different disease populations
- The questionnaire can capture both quantitative differences (intensity/severity) and qualitative differences (domains of expression) in chronic fatigue
- CFS produces more extensive fatigue-related impairment than inflammatory bowel disease on multiple MCAS dimensions
- Future refinement is needed to reduce construct overlap between physical/interpersonal consequences and behavioral fatigue measures
Remaining Questions
- How does the MCAS perform in longitudinal follow-up studies, and can it detect meaningful change over time with treatment?
What This Study Does Not Prove
This study does not establish whether the MCAS predicts treatment response, prognosis, or recovery in ME/CFS. The single online survey design limits causal inference and generalizability beyond French-speaking populations. Cross-sectional data cannot determine whether the four dimensions represent distinct mechanisms or simply different expressions of a single underlying process.
Tags
Symptom:Fatigue
Method Flag:Weak Case DefinitionExploratory OnlyMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →